Citazione APA

Peer, C. J., Sissung, T. M., Kim, A., Jain, L., Woo, S., Gardner, E. R., . . . Figg, W. D. (2012). Sorafenib is an Inhibitor of UGT1A1 but is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia. Clin Cancer Res.

Stile di citazione Chicago

Peer, Cody J., et al. "Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized By UGT1A9: Implications of Genetic Variants On Pharmacokinetics and Hyperbilirubinemia." Clin Cancer Res 2012.

Citazione MLA

Peer, Cody J., et al. "Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized By UGT1A9: Implications of Genetic Variants On Pharmacokinetics and Hyperbilirubinemia." Clin Cancer Res 2012.

Attenzione: Queste citazioni potrebbero non essere precise al 100%.